SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma

MLA

Ma Z, et al. “SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.” Journal of Hepatocellular Carcinoma, vol. ume 8, Aug. 2021, pp. 899–912. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4942791c5ed24ff08f9843290dbe6201&authtype=sso&custid=ns315887.

APA

Ma Z, Li Z, Wang S, Zhou Q, Liu C, Huang B, Zheng Z, Yang L, Zou Y, Zhang C, Huang S, & Hou B. (2021). SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma, ume 8, 899–912.

Chicago

Ma Z, Li Z, Wang S, Zhou Q, Liu C, Huang B, Zheng Z, et al. 2021. “SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma.” Journal of Hepatocellular Carcinoma ume 8 (August): 899–912. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.4942791c5ed24ff08f9843290dbe6201&authtype=sso&custid=ns315887.